ArticleBMJ open2024

Cost-effectiveness of consolidation durvalumab for inoperable stage III non-small cell lung cancer in Vietnam.

Vu Quynh Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.